title: Why would the incidence of HIV-associated Hodgkin lymphoma increase in the setting of improved immunity?
authors.forename: Annunziata
authors.initials: A
authors.lastname: Gloghini
authors.forename: Antonino
authors.initials: A
authors.lastname: Carbone
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D017209:Apoptosis / Q000187:drug effects; D015704:CD4 Antigens / Q000276:immunology; D019013:CD40 Antigens / Q000276:immunology; D023201:CD40 Ligand / Q000276:immunology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006689:Hodgkin Disease / Q000150:complications / Q000276:immunology*; D006801:Humans; D008954:Models, Biological; D016539:Reed-Sternberg Cells / Q000276:immunology* / Q000473:pathology; D015398:Signal Transduction / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
chemical_list: D015704:CD4 Antigens; D019013:CD40 Antigens; D023201:CD40 Ligand